These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 31823199)

  • 1. Cannabidiol Improves Cognitive Impairment and Reverses Cortical Transcriptional Changes Induced by Ketamine, in Schizophrenia-Like Model in Rats.
    Kozela E; Krawczyk M; Kos T; Juknat A; Vogel Z; Popik P
    Mol Neurobiol; 2020 Mar; 57(3):1733-1747. PubMed ID: 31823199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabidiol improves behavioural and neurochemical deficits in adult female offspring of the maternal immune activation (poly I:C) model of neurodevelopmental disorders.
    Osborne AL; Solowij N; Babic I; Lum JS; Huang XF; Newell KA; Weston-Green K
    Brain Behav Immun; 2019 Oct; 81():574-587. PubMed ID: 31326506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabidiol Modulates the Motor Profile and NMDA Receptor-related Alterations Induced by Ketamine.
    Brakatselos C; Delis F; Asprogerakas MZ; Lekkas P; Tseti I; Tzimas PS; Petrakis EA; Halabalaki M; Skaltsounis LA; Antoniou K
    Neuroscience; 2021 Feb; 454():105-115. PubMed ID: 32950556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of cannabidiol on endocannabinoid, glutamatergic and GABAergic signalling markers in male offspring of a maternal immune activation (poly I:C) model relevant to schizophrenia.
    Osborne AL; Solowij N; Babic I; Lum JS; Newell KA; Huang XF; Weston-Green K
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Dec; 95():109666. PubMed ID: 31202911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabidiol attenuates sensorimotor gating disruption and molecular changes induced by chronic antagonism of NMDA receptors in mice.
    Gomes FV; Issy AC; Ferreira FR; Viveros MP; Del Bel EA; Guimarães FS
    Int J Neuropsychopharmacol; 2014 Oct; 18(5):. PubMed ID: 25618402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabidiol attenuates behavioral changes in a rodent model of schizophrenia through 5-HT1A, but not CB1 and CB2 receptors.
    Rodrigues da Silva N; Gomes FV; Sonego AB; Silva NRD; Guimarães FS
    Pharmacol Res; 2020 Jun; 156():104749. PubMed ID: 32151683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of cannabidiol on muscarinic neurotransmission in the pre-frontal cortex and hippocampus of the poly I:C rat model of schizophrenia.
    Jimenez Naranjo C; Osborne AL; Weston-Green K
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Aug; 94():109640. PubMed ID: 31108177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-lipoic acid alone and combined with clozapine reverses schizophrenia-like symptoms induced by ketamine in mice: Participation of antioxidant, nitrergic and neurotrophic mechanisms.
    Vasconcelos GS; Ximenes NC; de Sousa CN; Oliveira Tde Q; Lima LL; de Lucena DF; Gama CS; Macêdo D; Vasconcelos SM
    Schizophr Res; 2015 Jul; 165(2-3):163-70. PubMed ID: 25937462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripubertal cannabidiol treatment rescues behavioral and neurochemical abnormalities in the MAM model of schizophrenia.
    Stark T; Ruda-Kucerova J; Iannotti FA; D'Addario C; Di Marco R; Pekarik V; Drazanova E; Piscitelli F; Bari M; Babinska Z; Giurdanella G; Di Bartolomeo M; Salomone S; Sulcova A; Maccarrone M; Wotjak CT; Starcuk Z; Drago F; Mechoulam R; Di Marzo V; Micale V
    Neuropharmacology; 2019 Mar; 146():212-221. PubMed ID: 30496751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased glial reactivity could be involved in the antipsychotic-like effect of cannabidiol.
    Gomes FV; Llorente R; Del Bel EA; Viveros MP; López-Gallardo M; Guimarães FS
    Schizophr Res; 2015 May; 164(1-3):155-63. PubMed ID: 25680767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex-Specific Cannabidiol- and Iloperidone-Induced Neuronal Activity Changes in an In Vitro MAM Model System of Schizophrenia.
    Thériault RK; St-Denis M; Hewitt T; Khokhar JY; Lalonde J; Perreault ML
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CBD Effects on Motor Profile and Neurobiological Indices Related to Glutamatergic Function Induced by Repeated Ketamine Pre-Administration.
    Poulia N; Delis F; Brakatselos C; Ntoulas G; Asprogerakas MZ; Antoniou K
    Front Pharmacol; 2021; 12():746935. PubMed ID: 34776964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabidiol prevents disruptions in sensorimotor gating induced by psychotomimetic drugs that last for 24-h with probable involvement of epigenetic changes in the ventral striatum.
    Pedrazzi JFC; Sales AJ; Guimarães FS; Joca SRL; Crippa JAS; Del Bel E
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Dec; 111():110352. PubMed ID: 34015384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of GABAergic, BDNF and Nox-2 mechanisms in the prevention and reversal of ketamine-induced schizophrenia-like behavior by morin in mice.
    Ben-Azu B; Aderibigbe AO; Ajayi AM; Eneni AO; Umukoro S; Iwalewa EO
    Brain Res Bull; 2018 May; 139():292-306. PubMed ID: 29548911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. mGlu
    Maksymetz J; Byun NE; Luessen DJ; Li B; Barry RL; Gore JC; Niswender CM; Lindsley CW; Joffe ME; Conn PJ
    Cell Rep; 2021 Nov; 37(5):109950. PubMed ID: 34731619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prenatal MAM exposure raises kynurenic acid levels in the prefrontal cortex of adult rats.
    Frescura F; Stark T; Tiziani E; Di Martino S; Ruda-Kucerova J; Drago F; Ferraro L; Micale V; Beggiato S
    Pharmacol Rep; 2024 Aug; 76(4):887-894. PubMed ID: 38789891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morin Attenuates Neurochemical Changes and Increased Oxidative/Nitrergic Stress in Brains of Mice Exposed to Ketamine: Prevention and Reversal of Schizophrenia-Like Symptoms.
    Ben-Azu B; Aderibigbe AO; Eneni AO; Ajayi AM; Umukoro S; Iwalewa EO
    Neurochem Res; 2018 Sep; 43(9):1745-1755. PubMed ID: 29956036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered dopamine D3 receptor gene expression in MAM model of schizophrenia is reversed by peripubertal cannabidiol treatment.
    Stark T; Di Bartolomeo M; Di Marco R; Drazanova E; Platania CBM; Iannotti FA; Ruda-Kucerova J; D'Addario C; Kratka L; Pekarik V; Piscitelli F; Babinska Z; Fedotova J; Giurdanella G; Salomone S; Sulcova A; Bucolo C; Wotjak CT; Starcuk Z; Drago F; Mechoulam R; Di Marzo V; Micale V
    Biochem Pharmacol; 2020 Jul; 177():114004. PubMed ID: 32360362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-level therapeutic actions of cannabidiol in ketamine-induced schizophrenia psychopathology in male rats.
    Brakatselos C; Polissidis A; Ntoulas G; Asprogerakas MZ; Tsarna O; Vamvaka-Iakovou A; Nakas G; Delis A; Tzimas P; Skaltsounis L; Silva J; Delis F; Oliveira JF; Sotiropoulos I; Antoniou K
    Neuropsychopharmacology; 2024 Dec; 50(2):388-400. PubMed ID: 39242923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Molecular Markers of Clozapine Action in Ketamine-Induced Cognitive Impairment: A GPCR Signaling PathwayFinder Study.
    Korlatowicz A; Kuśmider M; Szlachta M; Pabian P; Solich J; Dziedzicka-Wasylewska M; Faron-Górecka A
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.